Rabeprazole Sodium Delayed Release Tablets

RABEPRAZOLE SODIUM DR AWARD SPE2D2-20-D-0096

20MG 30 COUNT

20MG 90 COUNT

20MG 500 COUNT

Modification P00003 SPE2D220D0096 has been issued to invoke option year 2 effective August 27, 2022 through August 26, 2023.

Modification P00002 SPE2D220D0096 has been issued to invoke option year 1 effective August 27, 2021 through August 26, 2022.

Modification P00001 SPE2D220D0096 to incorporate FAR 52.204-24 and FAR 52.204-25 into subject contract.

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. Procurement details follow.

Rabeprazole Sodium DR 20MG in 30, 90 and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The .... Read More

Modification P00003 SPE2D220D0096 has been issued to invoke option year 2 effective August 27, 2022 through August 26, 2023.

Modification P00002 SPE2D220D0096 has been issued to invoke option year 1 effective August 27, 2021 through August 26, 2022.

Modification P00001 SPE2D220D0096 to incorporate FAR 52.204-24 and FAR 52.204-25 into subject contract.

The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Rabeprazole Sodium Delayed Release Tablets. Procurement details follow.

Rabeprazole Sodium DR 20MG in 30, 90 and 500 count bottles. This will be an unrestricted and fully competitive acquisition. The .... Read More